Ambu ASWBO:AMBU +0.28%63 Net Current Asset Value is €0.76 as of Mar. 2026, which is 100% below its 10-year median of 34.34. GuruFocus rates WBO:AMBU with a GF Score™ of 63/100 and a GF Value™ of €17.16 (Significantly Undervalued). Among 568 Medical Devices & Instruments companies, Ambu AS ranks worse than 75.7% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Ambu AS's net current asset value per share for the quarter that ended in Mar. 2026 was €0.76.
The historical rank and industry rank for Ambu AS's Net Current Asset Value or its related term are showing as below:
WBO:AMBU'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 11.68 Med: 34.34 Max: 4965
Current: 11.71
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Ambu AS was 4965.00. The lowest was 11.68. And the median was 34.34.
WBO:AMBU's Price-to-Net-Current-Asset-Value is ranked worse than 75.7% of 568
companies
in the Medical Devices & Instruments industry
Industry Median: 5.1
vs WBO:AMBU: 11.71
Ambu AS (WBO:AMBU) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Ambu AS Net Current Asset Value Related Terms
Ambu AS Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Ambu AS's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:AMBU vs ABT, SYK, MDT: Net Current Asset Value Comparison
For the Medical Devices subindustry, Ambu AS's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambu AS Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Ambu AS's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of €0.76 mean?
Ambu AS (WBO:AMBU) has a Net Current Asset Value of €0.76 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Ambu AS and its competitors. This is 98% below median its historical median of 34.34. Over the past decade, Ambu AS's Net Current Asset Value has ranged from 11.68 to 4,965.00. According to the industry distribution chart, Ambu AS ranks #430 out of 568 companies in the Medical Devices & Instruments industry, placing it in the top 75.7%.
Is Ambu AS's Net Current Asset Value too high?
Ambu AS's current Net Current Asset Value of €0.76 is 98% below median its 10-year median of 34.34. Over the past 10 years, this metric has ranged from a low of 11.68 to a high of 4,965.00. Based on the distribution chart, Ambu AS ranks #430 out of 568 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ambu AS has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Net Current Asset Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #430 out of 568 companies for Net Current Asset Value. This places Ambu AS in the lower half of its industry. The industry median Net Current Asset Value is 5.10. Historically, Ambu AS's own Net Current Asset Value has ranged from 11.68 to 4,965.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 5.10, based on 568 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Ambu AS and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 5.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambu AS's current Net Current Asset Value is €0.76, which is 98% below median its own 10-year median of 34.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (WBO:AMBU) is currently considered Significantly Undervalued. The stock's GF Value™ is €17.16, compared to a current price of €8.90 — trading 48.1% below its estimated fair value. The current Net Current Asset Value is €0.76, which is 98% below median its 10-year median of 34.34. Ambu AS's overall GF Score™ is 63/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Ambu AS (WBO:AMBU), the current Net Current Asset Value is €0.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (WBO:AMBU) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of €8.90 is trading 48.1% below its estimated GF Value™ of €17.16.
GuruFocus considers Ambu AS to be Significantly Undervalued.
Key valuation signals for WBO:AMBU:
Net Current Asset Value: €0.76 (98% below median its 10-year median of 34.34)
GF Value™: €17.16 vs. price of €8.90 (48.1% below fair value)
No single metric tells the full story. See the WBO:AMBU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
63GF Score
Get the complete analysis for WBO:AMBU
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:AMBU has been successfully added to your 
